OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species
Lei Peng, Zhenhao Fang, Paul Renauer, et al.
Cell Reports (2022) Vol. 40, Iss. 5, pp. 111160-111160
Open Access | Times Cited: 15
Lei Peng, Zhenhao Fang, Paul Renauer, et al.
Cell Reports (2022) Vol. 40, Iss. 5, pp. 111160-111160
Open Access | Times Cited: 15
Showing 15 citing articles:
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
Steven Μ. Albelda
Nature Reviews Clinical Oncology (2023) Vol. 21, Iss. 1, pp. 47-66
Closed Access | Times Cited: 160
Steven Μ. Albelda
Nature Reviews Clinical Oncology (2023) Vol. 21, Iss. 1, pp. 47-66
Closed Access | Times Cited: 160
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 109
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 109
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity
Yi You, Yu Tian, Rui Guo, et al.
European Heart Journal (2025)
Open Access | Times Cited: 1
Yi You, Yu Tian, Rui Guo, et al.
European Heart Journal (2025)
Open Access | Times Cited: 1
Broad-spectrum pan-genus and pan-family virus vaccines
Chee Wah Tan, Sophie Valkenburg, Leo L. M. Poon, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 6, pp. 902-916
Open Access | Times Cited: 22
Chee Wah Tan, Sophie Valkenburg, Leo L. M. Poon, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 6, pp. 902-916
Open Access | Times Cited: 22
mRNA Vaccines Contribute to Innate and Adaptive Immunity to Enhance Immune Response In Vivo
Qiannan Cao, Huapan Fang, Huayu Tian
Biomaterials (2024) Vol. 310, pp. 122628-122628
Closed Access | Times Cited: 8
Qiannan Cao, Huapan Fang, Huayu Tian
Biomaterials (2024) Vol. 310, pp. 122628-122628
Closed Access | Times Cited: 8
Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis
Christopher J. De Voss, Marcellus Korompis, Shuailin Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Christopher J. De Voss, Marcellus Korompis, Shuailin Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice
David R. Martinez, Alexandra Schäfer, Tyler D. Gavitt, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113248-113248
Open Access | Times Cited: 11
David R. Martinez, Alexandra Schäfer, Tyler D. Gavitt, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113248-113248
Open Access | Times Cited: 11
A new H9 influenza virus mRNA vaccine elicits robust protective immunity against infection
Shengkui Xu, Bowen Zhang, Jielin Yao, et al.
Vaccine (2023) Vol. 41, Iss. 18, pp. 2905-2913
Closed Access | Times Cited: 8
Shengkui Xu, Bowen Zhang, Jielin Yao, et al.
Vaccine (2023) Vol. 41, Iss. 18, pp. 2905-2913
Closed Access | Times Cited: 8
Circular RNAs in eukaryotic cells: origin, characteristics, mechanisms of molecular functioning in human malignant diseases
Vladimir I. Vashchenko, Alexey B. Chuklovin, Петр Д. Шабанов
Reviews on Clinical Pharmacology and Drug Therapy (2023) Vol. 20, Iss. 4, pp. 335-384
Open Access | Times Cited: 2
Vladimir I. Vashchenko, Alexey B. Chuklovin, Петр Д. Шабанов
Reviews on Clinical Pharmacology and Drug Therapy (2023) Vol. 20, Iss. 4, pp. 335-384
Open Access | Times Cited: 2
A Cocktail of Lipid Nanoparticle-mRNA Vaccines Broaden Immune Responses against β-Coronaviruses in a Murine Model
Yi Zhang, Jialu Zhang, Dongmei Li, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 484-484
Open Access
Yi Zhang, Jialu Zhang, Dongmei Li, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 484-484
Open Access
mRNA Vaccines for Malaria and Other Parasitic Pathogens
Leroy Versteeg, Jeroen Pollet
(2024), pp. 303-323
Closed Access
Leroy Versteeg, Jeroen Pollet
(2024), pp. 303-323
Closed Access
Lipid Nanoparticle (LNP) Delivery Vector-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
(2023)
Open Access | Times Cited: 1
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
(2023)
Open Access | Times Cited: 1
Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine
Wanting Li, Tiantian Zhao, Tao Bai, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access
Wanting Li, Tiantian Zhao, Tao Bai, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access
Can a pan-coronavirus vaccine limit the threat of SARS-CoV-2 emerging variants and prevent any future pandemic?
Hasanain Abdulhameed Odhar
(2023)
Open Access
Hasanain Abdulhameed Odhar
(2023)
Open Access
